Rallybio Announces In-Licensing of Potential First-In-Class Preclinical Antibody Candidate from Sanofi
Go back to Rallybio Announces In-Licensing of Potential First-In-Class Preclinical Antibody Candidate from Sanofi| (NASDAQ: RLYB) | Delayed: 15.67 -0.03 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.70 | 52 Week High | $ | |||
| Open | $15.85 | 52 Week Low | $ | |||
| Day High | $15.93 | P/E | N/A | |||
| Day Low | $15.62 | EPS | $ | |||
| Volume | 18,746 | |||||
